BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1010 related articles for article (PubMed ID: 16489297)

  • 1. Endoscopic surveillance in Barrett's esophagus.
    Lunedei V; Bazzoli F; Pozzato P; De Luca L; Zagari RM; Fossi S; Ricciardiello L; Maltoni S; Roda E
    Minerva Gastroenterol Dietol; 2002 Jun; 48(2):63-71. PubMed ID: 16489297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis and Management of Low-Grade Dysplasia in Barrett's Esophagus: Expert Review From the Clinical Practice Updates Committee of the American Gastroenterological Association.
    Wani S; Rubenstein JH; Vieth M; Bergman J
    Gastroenterology; 2016 Nov; 151(5):822-835. PubMed ID: 27702561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The development of dysplasia and adenocarcinoma during endoscopic surveillance of Barrett's esophagus.
    Katz D; Rothstein R; Schned A; Dunn J; Seaver K; Antonioli D
    Am J Gastroenterol; 1998 Apr; 93(4):536-41. PubMed ID: 9576444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysplasia in short-segment Barrett's esophagus: a prospective 3-year follow-up.
    Sharma P; Morales TG; Bhattacharyya A; Garewal HS; Sampliner RE
    Am J Gastroenterol; 1997 Nov; 92(11):2012-6. PubMed ID: 9362182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autofluorescence endoscopy in surveillance of Barrett's esophagus: a multicenter randomized trial on diagnostic efficacy.
    Borovicka J; Fischer J; Neuweiler J; Netzer P; Gschossmann J; Ehmann T; Bauerfeind P; Dorta G; Zürcher U; Binek J; Meyenberger C
    Endoscopy; 2006 Sep; 38(9):867-72. PubMed ID: 16981102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Barrett's esophagus and Barrett's-related dysplasia.
    Goldblum JR
    Mod Pathol; 2003 Apr; 16(4):316-24. PubMed ID: 12692197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimizing endoscopic biopsy detection of early cancers in Barrett's high-grade dysplasia.
    Reid BJ; Blount PL; Feng Z; Levine DS
    Am J Gastroenterol; 2000 Nov; 95(11):3089-96. PubMed ID: 11095322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience.
    Chennat J; Konda VJ; Ross AS; de Tejada AH; Noffsinger A; Hart J; Lin S; Ferguson MK; Posner MC; Waxman I
    Am J Gastroenterol; 2009 Nov; 104(11):2684-92. PubMed ID: 19690526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Barrett's surveillance identifies patients with early esophageal adenocarcinoma.
    Wong T; Tian J; Nagar AB
    Am J Med; 2010 May; 123(5):462-7. PubMed ID: 20399324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Surveillance of patients with Barrett's esophagus].
    Endlicher E; Knüchel R; Messmann H
    Z Gastroenterol; 2001 Aug; 39(8):593-600. PubMed ID: 11558064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A guide for surveillance of patients with Barrett's esophagus.
    Provenzale D; Kemp JA; Arora S; Wong JB
    Am J Gastroenterol; 1994 May; 89(5):670-80. PubMed ID: 8172136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Practice patterns for surveillance of Barrett's esophagus in the united states.
    Falk GW; Ours TM; Richter JE
    Gastrointest Endosc; 2000 Aug; 52(2):197-203. PubMed ID: 10922091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of proton pump inhibitors on markers of risk for high-grade dysplasia and oesophageal cancer in Barrett's oesophagus.
    Hillman LC; Chiragakis L; Shadbolt B; Kaye GL; Clarke AC
    Aliment Pharmacol Ther; 2008 Feb; 27(4):321-6. PubMed ID: 18047565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Barrett's esophagus can and does regress after antireflux surgery: a study of prevalence and predictive features.
    Gurski RR; Peters JH; Hagen JA; DeMeester SR; Bremner CG; Chandrasoma PT; DeMeester TR
    J Am Coll Surg; 2003 May; 196(5):706-12; discussion 712-3. PubMed ID: 12742201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and treatment of Barrett's oesophagus. A general survey.
    Petrakis IE; Sciacca V; Iascone C
    Acta Chir Belg; 2001; 101(2):53-8. PubMed ID: 11396051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of esophageal adenocarcinoma detected during endoscopic biopsy surveillance for Barrett's esophagus.
    Incarbone R; Bonavina L; Saino G; Bona D; Peracchia A
    Surg Endosc; 2002 Feb; 16(2):263-6. PubMed ID: 11967675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic four-quadrant biopsy detects Barrett's dysplasia in more patients than nonsystematic biopsy.
    Abela JE; Going JJ; Mackenzie JF; McKernan M; O'Mahoney S; Stuart RC
    Am J Gastroenterol; 2008 Apr; 103(4):850-5. PubMed ID: 18371135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromoendoscopy and magnification endoscopy for diagnosing esophageal cancer and dysplasia.
    Connor MJ; Sharma P
    Thorac Surg Clin; 2004 Feb; 14(1):87-94. PubMed ID: 15382312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term follow-up of Barrett's high-grade dysplasia.
    Weston AP; Sharma P; Topalovski M; Richards R; Cherian R; Dixon A
    Am J Gastroenterol; 2000 Aug; 95(8):1888-93. PubMed ID: 10950031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Barrett's esophagus: a retrospective analysis of 13 years surveillance.
    Switzer-Taylor V; Schlup M; Lübcke R; Livingstone V; Schultz M
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1362-7. PubMed ID: 18205769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.